Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income $ 53,984 $ 343,629
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 11,063 11,616
Valuation adjustment of mortgage servicing rights 4,904 (247,439)
Valuation adjustment of mortgage loans held for sale 3,611 65,297
Valuation adjustment of reverse mortgage loans held for investment and HMBS-related borrowings (5,061) 0
Unrealized gain on derivatives (26,454) (22,366)
Amortization of right-of-use assets 16,219 12,408
Provision for investor reserves 8,047 679
Provision for (reversal of) foreclosure losses 554 (1,974)
Valuation adjustment of contingent liabilities, net due to acquisitions 865 (45,075)
Gain on sale of mortgage loans excluding fair value of other financial instruments, net (247,547) (440,974)
Earnings from unconsolidated joint ventures, net of distributions received (165) 0
Paid-in-kind interest income (156) 0
Deferred income taxes 18,420 98,373
Other 1,637 (8,277)
Benefit from investor reserves (4,119) (3,101)
Foreclosure loss reserve (3,058) (1,436)
Stock-based compensation 6,417 4,917
Changes in operating assets and liabilities:    
Origination of mortgage loans held for sale (10,910,122) (16,265,741)
Proceeds on sale of and payments from mortgage loans held for sale 11,067,062 17,916,073
Accounts, notes and interest receivable 17,212 39,674
Other assets 3,497 (2,945)
Mortgage servicing rights (123,678) (206,772)
Accounts payable and accrued expenses (2,827) (15,932)
Accrued compensation and benefits 3,602 (39,622)
Income taxes 18,210 4,938
Contingent liability payments 0 (7,125)
Operating lease liabilities (16,810) (12,075)
Deferred compensation plan liability (4,663) 4,530
Real estate owned, net (1,315) (199)
Net cash (used in) provided by operating activities (110,671) 1,181,081
Cash flows from investing activities    
Acquisition of businesses (8,030) 0
Origination and purchase of reverse mortgage loans held for investment (77,297) 0
Principal payments received on reverse mortgage loans held for investment 734 0
Investments in unconsolidated joint ventures (913) 0
Distributions received from unconsolidated joint ventures in excess of cumulative earnings 236 0
Excess cash received over cash paid for investment in consolidated joint venture 320 0
Issuance of notes receivable (16,250) 0
Proceeds from the sale of property and equipment 3 177
Purchases of property and equipment (4,647) (3,158)
Net cash used in investing activities (105,844) (2,981)
Cash flows from financing activities    
Borrowings on warehouse lines of credit 11,078,901 16,006,430
Repayments on warehouse lines of credit (10,951,552) (17,113,148)
Proceeds from sale of reverse mortgage loans (HECMs) accounted for as HMBS-related obligations 71,445 0
Borrowings on MSR notes payable 148,766 0
Repayments on MSR notes payable (126,250) (137,500)
Contingent liability payments 0 (7,300)
Net change in notes payable (530) (1,784)
Taxes paid related to net share settlement of equity awards (524) 0
Repurchases of Class A common stock (2,132) (2,968)
Dividends paid (30,479) 0
Net cash provided by (used in) financing activities 187,645 (1,256,270)
Decrease in cash, cash equivalents and restricted cash (28,870) (78,170)
Cash, cash equivalents and restricted cash, beginning of period 146,754 248,120
Cash, cash equivalents and restricted cash, end of period 117,884 169,950
Cash, cash equivalents and restricted cash at end of period are comprised of the following:    
Cash and cash equivalents 114,352 162,198
Restricted cash 3,532 7,752
Total cash, cash equivalents and restricted cash 117,884 169,950
Supplemental information    
Cash paid for interest, net 12,091 26,291
Cash paid for income taxes, net of refunds (17,438) (3,745)
Supplemental disclosure of non-cash investing activities:    
Measurement period adjustments to goodwill $ 760 $ (1,710)